Grantee in the News: Domenico Praticò’s research on VPS35 Preventing Toxic Tau Buildup in Molecular Psychiatry
On July 9, 2019, Molecular Psychiatry published a study co-authored by AFAR expert Domenico Praticò, MD, that explores how the molecule VPS35 may play a vital role in helping to prevent the buildup of toxic tau, a protein that tends to accumulate in the brains of people with Alzheimer’s disease. This is the first study to show that VPS35 has a role in tauopathy.
Dr. Praticò is a 1997 and 1999 AFAR Research Grant recipient. He is the Scott Richards North Star Charitable Foundation Chair for Alzheimer’s Research, and a Professor and Director of the Alzheimer’s Center at the Lewis Katz School of Medicine at Temple University.